Cardiovascular Revascularization Medicine
Volume 11, Issue 3 , Pages 163-166 , July 2010

Low ejection fraction documented during cardiac catheterization is significantly associated with long-term, all-cause mortality

  • Mohammad Reza Movahed

      Affiliations

    • Corresponding Author InformationCorresponding author. University of Arizona School of Medicine, Southern Arizona VA Health Care System, University of Arizona Sarver Heart Center, 1501 North Campbell Avenue, Tucson, AZ 85724, USA.
    • ,
  • Sudhakar Sattur

Received 31 March 2009 ,Revised 29 April 2009 ,Accepted 30 April 2009.

References 

  1. Cohn JN, et al. Report of the National Heart, Lung, and Blood Institute special emphasis panel on heart failure research. Circulation. 1997;95(4):766–770
  2. Myerburg RJ. Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol. 2001;12(3):369–381
  3. Curtis JP, et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol. 2003;42(4):736–742
  4. Halkin A, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol. 2005;45(9):1397–1405
  5. Shiga T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era. Results from the HIJAMI-II Registry. Heart. 2008;
  6. Solomon SD, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112(24):3738–3744
  7. van der Vleuten PA, et al. The importance of left ventricular function for long-term outcome after primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2008;8:4
  8. Gosselink AT, et al. Prognostic value of predischarge radionuclide ventriculography at rest and exercise after acute myocardial infarction treated with thrombolytic therapy or primary coronary angioplasty. The Zwolle Myocardial Infarction Study Group. Clin Cardiol. 1998;21(4):254–260
  9. Nunez J, et al. Prognostic value of the left ventricular ejection fraction in patients with acute heart failure. Med Clin (Barc). 2008;131(5):161–166
  10. Sanz G, et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982;306(18):1065–1070
  11. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309(6):331–336
  12. Moss AJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–883
  13. Khalil ME, et al. A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol. 2001;37(7):1757–1764
  14. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357(9266):1385–1390

PII: S1553-8389(09)00196-1

doi: 10.1016/j.carrev.2009.04.110

Cardiovascular Revascularization Medicine
Volume 11, Issue 3 , Pages 163-166 , July 2010

Article Tools

* Image Usage & Resolution